Dr. Amandeep Kaur Rakhra, DO

Dr. Rakhra practices at CHI Health Clinic West Broadway - HOPD in Council Bluffs, Iowa.

Dr. Rakhra's NPI, 1720430184, was assigned on July 11, 2016. Dr. Rakhra graduated from University of Pikeville-Kentucky College of Osteopathic Medicine (KYCOM) in 2016. Dr. Rakhra holds Nebraska license 2059.

Dr. Rakhra's primary practice is CHI Health Clinic West Broadway - HOPD, at 3135 W Broadway, Council Bluffs, IA 51501.

Dr. Rakhra's primary practice is CHI Health Clinic West Broadway - HOPD in Council Bluffs, Iowa. Dr. Rakhra is also affiliated with CHI Health Mercy Council Bluffs. The medical group on file is CHI Health Clinic. Dmand AI also links Dr. Rakhra to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account. Dr. Rakhra's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rakhra practices, 6 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Rakhra's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Rakhra is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Rakhra's licenses on file in 2 states: Nebraska and New Hampshire.

Dmand AI lists arteritis, arthritis, fibromyalgia and chronic pain, fluid in a joint, gout, joint arthropathy, joint pain and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Rakhra treats.

CMS data shows 711 Medicare services from Dr. Rakhra across 10 procedure codes in 2024, for 206 Medicare patients. Medicare paid $38,938 for them. Every service was in an office.

CMS counts 206 Medicare patients who saw Dr. Rakhra in 2024. The largest group is 65 to 74, with 109 patients. 75% of them have arthritis, and 73% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.39, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rakhra's median patient age at 60, with 73% women.

In 2024, Dr. Rakhra wrote 861 Medicare Part D claims for 203 patients. 87% of them were for generic drugs. CMS names the drug for 732 of them, across 19 drugs with 11 or more claims each, at $167,630 in total drug cost. In 2023, CMS named 343 claims across 11 drugs.

Dr. Rakhra accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rakhra as offering telehealth.

Dmand AI links 4 papers to Dr. Rakhra, published from 2018 to 2021. 2018 was the busiest year, with 2. Dr. Rakhra has published most often in Cureus. Dr. Rakhra's most frequent co-authors are Thamer Kassim, MD, Mohammad Selim, MD and Javaneh Jabbari, MD.

CMS Open Payments shows 472 general payments to Dr. Rakhra from 37 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 80% of the total. Janssen Pharmaceuticals, Inc paid the most, $3,181.

Dr. Rakhra graduated from University of Pikeville-Kentucky College of Osteopathic Medicine (KYCOM) in 2016.

Dr. Rakhra is in network with 14 carriers, including Elevance, United Healthcare and Medica. HMO plans come from the most carriers, 9. Check the plan with the practice before a visit.